Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 1.505 AUD 1.35% Market Closed
Market Cap: 1.7B AUD
Have any thoughts about
Mesoblast Ltd?
Write Note

Relative Value

The Relative Value of one MSB stock under the Base Case scenario is 5.096 AUD. Compared to the current market price of 1.505 AUD, Mesoblast Ltd is Undervalued by 70%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MSB Relative Value
Base Case
5.096 AUD
Undervaluation 70%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
13
Median 3Y
51.8
Median 5Y
52.1
Industry
7.7
Forward
114
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-7.5
Industry
22.7
Forward
-24.2
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-9
Industry
21.6
vs History
vs Industry
Median 3Y
-6.9
Median 5Y
-8.7
Industry
25.2
vs History
12
vs Industry
47
Median 3Y
1
Median 5Y
1.2
Industry
2.5
vs History
0
vs Industry
11
Median 3Y
54.8
Median 5Y
55.1
Industry
7.7
Forward
118.1
vs History
vs Industry
Median 3Y
-27.1
Median 5Y
-26.6
Industry
9
vs History
vs Industry
Median 3Y
-7.1
Median 5Y
-7.7
Industry
4.2
Forward
-19.6
vs History
vs Industry
Median 3Y
-7.1
Median 5Y
-7.7
Industry
4.1
Forward
-18.1
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-8.6
Industry
5.7
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-8.5
Industry
3.6
vs History
15
vs Industry
51
Median 3Y
0.9
Median 5Y
1.1
Industry
4.6

Multiples Across Competitors

MSB Competitors Multiples
Mesoblast Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Mesoblast Ltd
ASX:MSB
1.7B AUD 189.3 -12.7 -17.3 -17.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
AU
Mesoblast Ltd
ASX:MSB
Average P/E: 208.3
Negative Multiple: -12.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
AU
Mesoblast Ltd
ASX:MSB
Average EV/EBITDA: 17.2
Negative Multiple: -17.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
AU
Mesoblast Ltd
ASX:MSB
Average EV/EBIT: 22.5
Negative Multiple: -17.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top